SCHEMBL6562049

SCHEMBL6562049

CC(C)(C)OC(=O)N=C(N)S

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL320541 0.81 DGAT1 (0.34) DGAT1
SCHEMBL17348031 0.79 DGAT1 (0.33) DGAT1
SCHEMBL17083255 0.79 DGAT1 (0.33) DGAT1
SCHEMBL8879857 0.76 DGAT1 (0.31) DGAT1
SCHEMBL8750078 0.76 DGAT1 (0.31) DGAT1
SCHEMBL6379683 0.74 DGAT1 (0.34) DGAT1
SCHEMBL15324947 0.74 DGAT1 (0.30) DGAT1
SCHEMBL12317214 0.74 NOS1 (0.43) DGAT1
SCHEMBL1136775 0.74 NOS1 (0.43) DGAT1
SCHEMBL28705194 0.74 DGAT1 (0.34) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0933993-A4 SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARM INC (US) 2004-09-08 EP disclosed
EP-0933993-A1 SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARMACEUTICALS INC. (US) 1999-08-11 EP disclosed
WO-1997047194-A1 SUBSTITUTED CYCLOPENTANE COMPOUNDS USEFUL AS NEURAMINIDASE INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 1997-12-18 WO disclosed